Advertisement

Human Genetics

, Volume 116, Issue 4, pp 319–328 | Cite as

Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans

  • Seong-Gene Lee
  • Yeonho Joo
  • Byungsu Kim
  • Seockhoon Chung
  • Hie-Lim Kim
  • Inchul Lee
  • Boyoul Choi
  • Changyoon Kim
  • Kyuyoung SongEmail author
Original Investigation

Abstract

Catechol-O-methyltransferase (COMT) inactivates circulating catechol hormones, catechol neurotransmitters, and xenobiotic catecholamines by methylating their catechol moieties. The COMT gene has been suggested as a candidate gene for schizophrenia through linkage analyses and molecular studies of velo-cardio-facial syndrome. A coding polymorphism of the COMT gene at codon 108/158 (soluble/membrane-bound form) causing a valine to methionine substitution has been shown to influence enzyme activity, but its association with schizophrenia is inconclusive. We have screened 17 known polymorphisms of the COMT gene in 320 Korean schizophrenic patients and 379 controls to determine whether there is a positive association with a nonsynonymous single-nucleotide polymorphism (rs6267) at codon 22/72 (soluble/membrane-bound form) causing an alanine-to-serine (Ala/Ser) substitution. With the Ala/Ala genotype as a reference group, the combined genotype (Ala/Ser and Ser/Ser)-specific adjusted odds ratio was 1.82 (95% CI=1.19–2.76; P=0.005), suggesting the Ser allele as a risk allele for schizophrenia. However, the Val/Met polymorphism was not associated with an increased risk of schizophrenia in Koreans (OR=0.88, 95% CI=0.64–1.21; P=0.43). The Ala72Ser substitution was correlated with reduced COMT enzyme activity. Our results support previous reports that the COMT haplotype implicated in schizophrenia is associated with low COMT expression.

Keywords

Schizophrenia COMT Gene Val158Met Polymorphism COMT Activity COMT Genotype 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

We thank Yongsook Yoon, Jeongsun Lee, and Sunyoung Lee for excellent technical assistance. This work was supported by the grants to K.S. from the Korean HapMap Project of MOST (Ministry of Science and Technology of Korea) and the Basic Research Grant R04-2004-000-10228-0 of KOSEF.

References

  1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 4th ed. American Psychiatric Association, Washington DCGoogle Scholar
  2. Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702–705PubMedGoogle Scholar
  3. Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm HW, Malherbe P (1991) Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 88:1416–1420Google Scholar
  4. Boudikova B, Szumlanski C, Maidak B, Weinshilboum R (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48:381–389CrossRefGoogle Scholar
  5. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O’Donovan MC (2003) A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152–161CrossRefPubMedGoogle Scholar
  6. Bromet E, Fennig S (1999) Epidemiology and natural history of schizophrenia. Biol Psychiatry 46:871–881CrossRefGoogle Scholar
  7. Brzustowicz L, Honer W, Chow E, Little D, Hogan J, Hodgkinson K, Bassett AS (1999) Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 65:1096–1103CrossRefGoogle Scholar
  8. Brzustowicz L, Hodgkinson K, Chow E, Honer W, Bassett A (2000) Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678–682CrossRefGoogle Scholar
  9. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179–186PubMedGoogle Scholar
  10. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ (1997) Association study of NlaIII and MspI genetic polymorphisms of erythrocyte catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 41:985–987CrossRefGoogle Scholar
  11. Chen CH, Lee YR, Chung MY, Wei FC, Koong FJ, Shaw CK, Yeh JI, Hsiao KJ (1999) Systemic mutation analysis of the catechol-O-methyltransferase gene as a candidate gene for schizophrenia. Am J Psychiatry 156:1273–1275Google Scholar
  12. Cohn CK, Dunner DL, Axelrod J (1970) Reduced catechol-O-methyltransferase activity in red blood cell of women with primary affective disorder. Science 170:1323–1324Google Scholar
  13. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Spurlock G, Riley B, Scambler P, Asherson P, McGuffin P, Owen MJ (1996) No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 153:268–270Google Scholar
  14. Dunham I, Collins J, Wadey R, Scambler P (1992) Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 340:1361–1362CrossRefGoogle Scholar
  15. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917–6922CrossRefPubMedGoogle Scholar
  16. Gershon ES, Jonas WZ (1975) Erythrocyte soluble catechol-O-methyltransferase activity in primary affective disorder. Arch Gen Psychiatry 32:1351–1356Google Scholar
  17. Glatt SJ, Faraone SV, Tsuang MT (2003) Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 160:469–476CrossRefGoogle Scholar
  18. Grossman MH, Littrell JB, Weinstein R, Szumlanski C, Weinshilboum RM (1992) Identification of the possible molecular basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc (Abstr) 18:70Google Scholar
  19. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92:7612–7616Google Scholar
  20. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA (1997) Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572–4575CrossRefPubMedGoogle Scholar
  21. Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, Schulze TG, Reshef A, Blanaru M, Gathas S, Goichman R, Rietschel M, Dobrusin M, Bachner-Melman R, Nemanov L, Belmaker RH, Maier W, Ebstein RP (2003) Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet 119B: 35–39CrossRefGoogle Scholar
  22. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250PubMedGoogle Scholar
  23. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J (1998) Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155:835–837Google Scholar
  24. Lee S, Hong S, Yoon Y, Yang I, Song K (2001) Characterization of publicly available SNPs in the Korean population. Hum Mutat 17:281–284CrossRefGoogle Scholar
  25. Lewander T, Pongracz G von, Backstrom M, Wetterberg L (1981) Dopamine metabolism in red blood cells in schizophrenia. Clin Genet 19:410–413Google Scholar
  26. Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:849–852PubMedGoogle Scholar
  27. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM, Liu X, Collier DA (1996) Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatry Genet 6:131–133Google Scholar
  28. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC, Collier DA (2000) Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 5:77–84 (erratum 5:452)CrossRefGoogle Scholar
  29. Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC (2001) Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology 43:11–14CrossRefGoogle Scholar
  30. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202–4210PubMedGoogle Scholar
  31. Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I (1991) Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 10:181–189Google Scholar
  32. McLeod HL, Syvanen AC, Githang’a J, Indalo A, Ismail D, Dewar K, Ulmanen I, Sludden J (1998) Ethnic differences in catechol-O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or south-west Asian individuals. Pharmacogenetics 8:195–199Google Scholar
  33. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor M, Semple C, Devon RS, Clair DM, Muir WJ, Blackwood DH, Porteous DJ (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415–1423CrossRefGoogle Scholar
  34. Morrow B, Goldberg R, Carlson C, Gupta RD, Sirotkin H, Collins J, Dunham I, O’Donnell H, Scambler P, Shprintzen R, Kucherlapati R (1995) Molecular definition of the 22q11 deletion in velocardio facial syndrome. Am J Hum Genet 56:1391–1403Google Scholar
  35. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940–945CrossRefGoogle Scholar
  36. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, Abe K (1998) Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243:109–112CrossRefGoogle Scholar
  37. Palmatier MA, Kang AM, Kidd KK (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46:557–567CrossRefPubMedGoogle Scholar
  38. Park TW, Yoon KS, Kim JH, Park WY, Hirvonen A, Kang D (2002) Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol 12:299–303CrossRefGoogle Scholar
  39. Rivera-Calimlim L, Reilly DK (1984) Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance. Clin Pharmacol Ther 35:804–809Google Scholar
  40. Saito S, Iida A, Sekine A, Miura Y, Sakamoto T, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y (2001) Identification of 197 genetic variations in six human methyltransferase genes in the Japanese population. J Hum Genet 46:529–537CrossRefPubMedGoogle Scholar
  41. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, Lichtermann D, Minges J, Bondy B, Ackenheil M, Altmark D, Hasib D, Gur E, Ebstein RP, Wildenauer DB (1995) Potential linkage for schizophrenia on chromosome 22q12-q13: a replication study. Am J Med Genet 60:436–443Google Scholar
  42. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM (2004) Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9:151–160CrossRefGoogle Scholar
  43. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296–1302CrossRefPubMedGoogle Scholar
  44. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877–892CrossRefGoogle Scholar
  45. Straub RE, MacLean CJ, O’Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Webb BT, Zhang J, Walsh D, Kendler KS (1995) A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity. Nat Genet 11:287–293CrossRefGoogle Scholar
  46. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM (1997a) Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69:71–77CrossRefPubMedGoogle Scholar
  47. Strous RD, Bark N, Woerner M, Lachman HM (1997b) Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41:493–495CrossRefGoogle Scholar
  48. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM (2003) Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet 120B: 29–34CrossRefGoogle Scholar
  49. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I (1997) Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 7:65–71Google Scholar
  50. Tsuang M (2000) Schizophrenia: genes and environment. Biol Psychiatry 47:210–220CrossRefGoogle Scholar
  51. Weinshilboum RM, Raymond FA (1977) Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 29:125–135Google Scholar
  52. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1974) Correlation of erythrocyte catechol-O-methyltransferase activity between siblings. Nature 252:490–491Google Scholar
  53. Xie T, Ho SL, Ramsden D (1999) Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56:31–38Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Seong-Gene Lee
    • 1
    • 2
  • Yeonho Joo
    • 3
  • Byungsu Kim
    • 3
  • Seockhoon Chung
    • 3
  • Hie-Lim Kim
    • 4
  • Inchul Lee
    • 5
  • Boyoul Choi
    • 6
  • Changyoon Kim
    • 3
  • Kyuyoung Song
    • 4
    Email author
  1. 1.Asan Institute for Life SciencesUniversity of Ulsan College of MedicineSeoulKorea
  2. 2.Department of Biotechnology, College of Agriculture and Life SciencesChonnam National UniversityGwangjuKorea
  3. 3.Department of PsychiatryUniversity of Ulsan College of MedicineSeoulKorea
  4. 4.Department of Biochemistry and Molecular BiologyUniversity of Ulsan College of MedicineSeoulKorea
  5. 5.Department of PathologyUniversity of Ulsan College of MedicineSeoulKorea
  6. 6.Department of Preventive Medicine, College of MedicineHanyang UniversitySeoulKorea

Personalised recommendations